Alterity Therapeutics Limited (ATHE) Social Stream
ALTERITY THERAPEUTICS LTD (ATHE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ALTERITY THERAPEUTICS LTD.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ATHE reports an average of 1,740.02% for its upside potential over the past 32 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ATHE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 15 months, ATHE's average broker recommendation rating worsened by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ATHE has a greater number of analysts covering the stock than 19.25% of all US stocks.
- In the context of stocks in the small market cap category, ALTERITY THERAPEUTICS LTD's upside potential (average analyst target price relative to current price) is higher than 111.47% of them.
- ALTERITY THERAPEUTICS LTD's average analyst price target is greater than 94.37% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ALTERITY THERAPEUTICS LTD's variance in analysts' estimates is lower than -151.84% of them.
In the Pharmaceutical Products industry, VRNA, URGN, and PRTK are the three stocks most similar to ALTERITY THERAPEUTICS LTD regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding ATHE using the data that counts. Try POWR Ratings for free.